These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24465624)

  • 21. Second-line rescue treatment of
    Lin TF; Hsu PI
    World J Gastroenterol; 2018 Oct; 24(40):4548-4553. PubMed ID: 30386104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line.
    Di Caro S; Fini L; Daoud Y; Grizzi F; Gasbarrini A; De Lorenzo A; Di Renzo L; McCartney S; Bloom S
    World J Gastroenterol; 2012 Oct; 18(40):5669-78. PubMed ID: 23155306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication.
    Chuah SK; Liang CM; Lee CH; Chiou SS; Chiu YC; Hu ML; Wu KL; Lu LS; Chou YP; Chang KC; Kuo CH; Kuo CM; Hu TH; Tai WC
    Medicine (Baltimore); 2016 May; 95(19):e3586. PubMed ID: 27175657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Levofloxacin-based triple therapy versus bismuth-based quadruple therapy in the treatment of
    Zhang M; Chen CY; Wang XT; Lyu B
    Zhonghua Nei Ke Za Zhi; 2017 May; 56(5):368-374. PubMed ID: 28460509
    [No Abstract]   [Full Text] [Related]  

  • 25. Helicobacter pylori Eradication Rates in Slovenia in the Period from 2017 to 2019: Data from the European Registry on H. pylori Management.
    Tepes B; Brglez Jurecic N; Tepes K; Espada Sanchez M; Perez Nyssen O; O'Morain C; Mégraud F; Gisbert J
    Dig Dis; 2021; 39(4):318-324. PubMed ID: 33099549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
    Nista EC; Candelli M; Zocco MA; Cremonini F; Ojetti V; Finizio R; Spada C; Cammarota G; Gasbarrini G; Gasbarrini A
    Am J Gastroenterol; 2006 Sep; 101(9):1985-90. PubMed ID: 16968503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection.
    Fu W; Song Z; Zhou L; Xue Y; Ding Y; Suo B; Tian X; Wang L
    Dig Dis Sci; 2017 Jun; 62(6):1580-1589. PubMed ID: 28391418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eradication Rate by Duration of Third-line Rescue Therapy with Levofloxacin after Helicobacter pylori Treatment Failure in Clinical Practice.
    Noh HM; Hong SJ; Han JP; Park KW; Lee YN; Lee TH; Ko BM; Lee JS; Lee MS
    Korean J Gastroenterol; 2016 Nov; 68(5):260-264. PubMed ID: 27871162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
    Assem M; El Azab G; Rasheed MA; Abdelfatah M; Shastery M
    Eur J Intern Med; 2010 Aug; 21(4):310-4. PubMed ID: 20603042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial.
    Kamal A; Ghazy RM; Sherief D; Ismail A; Ellakany WI
    BMC Infect Dis; 2023 Jan; 23(1):36. PubMed ID: 36670359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis.
    Kuo YT; Liou JM; El-Omar EM; Wu JY; Leow AHR; Goh KL; Das R; Lu H; Lin JT; Tu YK; Yamaoka Y; Wu MS;
    Lancet Gastroenterol Hepatol; 2017 Oct; 2(10):707-715. PubMed ID: 28781119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?
    Almeida N; Donato MM; Romãozinho JM; Luxo C; Cardoso O; Cipriano MA; Marinho C; Fernandes A; Calhau C; Sofia C
    BMC Gastroenterol; 2015 Feb; 15():23. PubMed ID: 25886722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimum duration of regimens for Helicobacter pylori eradication.
    Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis.
    Li Y; Huang X; Yao L; Shi R; Zhang G
    Wien Klin Wochenschr; 2010 Jul; 122(13-14):413-22. PubMed ID: 20628905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis.
    Xiao SP; Gu M; Zhang GX
    Scand J Gastroenterol; 2014 May; 49(5):528-38. PubMed ID: 24611790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection.
    Sereni G; Azzolini F; Camellini L; Formisano D; Decembrino F; Iori V; Tioli C; Cavina M; Di Mario F; Bedogni G; Sassatelli R
    World J Gastroenterol; 2012 Sep; 18(33):4542-8. PubMed ID: 22969227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetracycline-levofloxacin versus amoxicillin-levofloxacin quadruple therapies in the second-line treatment of Helicobacter pylori infection.
    Hsu PI; Tsay FW; Kao JY; Peng NJ; Chen YH; Tang SY; Kuo CH; Kao SS; Wang HM; Wu IT; Shie CB; Chuah SK; Wu DC;
    Helicobacter; 2021 Oct; 26(5):e12840. PubMed ID: 34390083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose rabeprazole-amoxicillin dual therapy and rabeprazole triple therapy with amoxicillin and levofloxacin for 2 weeks as first and second line rescue therapies for Helicobacter pylori treatment failures.
    Goh KL; Manikam J; Qua CS
    Aliment Pharmacol Ther; 2012 May; 35(9):1097-102. PubMed ID: 22404486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of 10-day levofloxacin bismuth-based quadruple therapy and levofloxacin-based triple therapy for Helicobacter pylori.
    Wu TS; Hsu PI; Kuo CH; Hu HM; Wu IC; Wang SSW; Chen YH; Wu DC; Su WW; Kuo FC
    J Dig Dis; 2017 Sep; 18(9):537-542. PubMed ID: 28644575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies.
    Sezgin O; Aydın MK; Özdemir AA; Kanık AE
    Turk J Gastroenterol; 2019 May; 30(5):420-435. PubMed ID: 31060997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.